$LIPO Cashflow Statement | Understand Stock

$LIPO

$0.00 +$0.00 (0.0%) Close

Financial Statements

In USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flow from operating activities:
Loss from operations
Depreciation and amortization
Shares issued for services
Non-cash stock option expense
Interest expense related party net (non-cash)
Changes in operating assets and liabilities:
Operating right of use asset
Grants receivable
Prepaid expense
Accounts payable
Accrued expenses
Payroll liability
Net cash used in operating activities
Cash flow from investing activities:
Sale of marketable securities
Purchase of Property, plant and equipment
Net cash used in investing activities
Cash flow from financing activities:
Proceeds from note payable
Proceeds from note payable, related party
Proceeds from issuance of Preferred Stock, Common Stock and pre-funded warrants, net of issuance costs
Repayment of notes payable, related party
Repayment of notes payable
Proceeds from issuance of common stock, net of issuance costs
Proceeds from issuance of warrants, net of issuance costs
Net cash provided by financing activities
Net decrease in cash, cash equivalents
Cash, and cash equivalents at beginning of period
Cash, and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Interest paid
Issuance of common stock for forgiveness of related party note
Income taxes paid
Issuance Common Stock options for consulting services

Comments